HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Product details
Registration number: SIN15910P
Classification: Prescription Only
Active ingredients: Oxaliplatin
Strength: 50 mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: GOLDPLUS UNIVERSAL PTE LTD
ATC code: L01XA03
HSA approval date: 16 March 2020
Manufacturer(s): Qilu Pharmaceutical (Hainan) Co. Ltd
Manufacturing country/countries: CHINA
What are the HSA registration number and classification for HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15910P
Classification: Prescription Only
What active ingredients and strength are recorded for HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Oxaliplatin
Strength: 50 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Which manufacturers and countries are listed for HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Qilu Pharmaceutical (Hainan) Co. Ltd
Manufacturing country/countries: CHINA
Where can I look up HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15910P or the exact product name HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL. The general register link does not preselect this product.
What are the source dates for this HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15910P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)